Laura Paulsen

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston.

Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT.

CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA.

Avaxia Biologics, Inc. operated as a clinical-stage biotechnology company. It engaged in the development of gut-targeted antibody therapeutics for gastroenterology indications. Gut-targeted antibody therapeutics is orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal (GI) tract including the mouth, throat, and intestines. The company was founded by David Poorvin and Barbara S. Fox in 2005 and was headquartered in Lexington, MA.

PhysIQ, Inc. provides proprietary predictive analytics for human physiology. It designs, develops and commercializes predictive analytics technologies to monitor the health of complex systems. The company was founded by Matt R. Pipke and Gary W. Conkright in 1999 and is headquartered in Naperville, IL.

SRS Medical Systems, Inc. manufactures medical devices for the diagnosis and conservative treatment of incontinence. Its products include The Spanner and The UroCuff Test. The company was founded by Kevin M. Connolly and John Reid in 1991 and is headquartered in North Billerica, MA.

OREX Computed Radiography Ltd. is an Israeli company that provides computed radiography system services. The company is based in Yokneam, Israel and was founded in 1995.

Amgen Ventures LLC (Amgen Ventures) is a venture capital firm, a subsidiary of Amgen, Inc. founded in 2004. The firm is headquartered in Thousand Oaks, California.

New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA.

20/20 HealthCare Partners LLC (20/20 HealthCare Partners) is a venture capital firm founded in 2005 by Hillel Bachrach. The firm is headquartered in Auburndale, Massachusetts.

Zixi LLC engages in the provision of content delivery at satellite and fiber operating metrics with internet based economic solutions. It operates in the following segments: Broadcast Media, sports and live events, house if worship, and over the top. The firm’s solutions include contribution, distribution, processing, and mobile content. The company was founded by Israel Drori and Uri Avni in 2006 and is headquartered in Waltham, MA.

Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel.

Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.

ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel.

Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

CathWorks Ltd. develops medical devices for the interventional cardiology market. Its technology is based on processing visual information and automatic multi-layered algorithms. The company was founded by Guy Lavi and Ifat Lavi in 2013 and is headquartered in Raanana, Israel.

Invicta Medical, Inc. operates as a medical technology company that develops wearable device for treatment of sleep apnea and snoring. Its device detects and treats disturbed breathing through electrical stimulation. The company was founded by Steven T. Kent and Harold Kent in 2013 and is headquartered in Portola Valley, CA.

Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada.

QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA.

ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany.

Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA.

Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation.

Xrhealth, Inc. is a healthcare company that utilizes spatial computing to revolutionize the industry. Xrhealth is based in Boston, MA, and its R&D center is located in Israel. The company operates virtual rooms that use proprietary FDA and CE registered medical extended reality (XR) technology, including virtual and augmented reality. Xrhealth integrates immersive XR technology, licensed clinicians, and advanced data analytics on one platform, providing a comprehensive therapeutic care solution for patients to receive treatment from the comfort of their home. The company offers a variety of patent-pending solutions from rehabilitation services to cognitive assessment and training to pain management. Xrhealth works with several world-renowned healthcare providers, hospitals, and rehabilitation centers. The company was founded by Michael Levy and Eran Orr, with Eran Orr serving as CEO since incorporation.

Nemdx, Inc. is a medical diagnostic platform that focuses on revealing critical information on protein function in neurodegenerative diseases.

The Thiel Foundation awards grants to groups that empower people to improve their lives, champions organizations and individuals who expose human rights abuses and authoritarianism. It programs include The Thiel Fellowship, Breakout Labs and Imitatio. The company is headquartered in San Francisco, CA.